-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Defining the Proteomic Landscape of Multiple Myeloma

Program: Scientific Program
Session: Proteo-Genomics to Better Study Multiple Myeloma Biology and Evolution
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Plasma Cell Disorders, Diseases, Lymphoid Malignancies, Technology and Procedures, Molecular testing, Omics technologies
Saturday, December 7, 2024, 9:30 AM-10:45 AM

Jan Kronke, MD

Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Disclosures: Kronke: Takeda: Consultancy, Honoraria; Sanofi: Consultancy, Honoraria, Speakers Bureau; Abbvie: Consultancy, Honoraria, Speakers Bureau; Pfizer: Honoraria; Janssen: Consultancy, Honoraria, Speakers Bureau; Astra Zeneca: Consultancy, Honoraria.

See more of: Proteo-Genomics to Better Study Multiple Myeloma Biology and Evolution
See more of: Scientific Program
Previous Presentation | Next Presentation >>